Emergent BioSolutions (EBS) Asset Writedowns and Impairment (2010 - 2026)
Emergent BioSolutions (EBS) posted quarterly Asset Writedowns and Impairment of $12.2 million for Q4 2025, down 55.15% quarter-over-quarter from $27.2 million in Q2 2024.
Emergent BioSolutions (EBS) Asset Writedowns and Impairment (2010 - 2026) Analysis & Trends
Emergent BioSolutions' Asset Writedowns and Impairment history runs 12 years deep, the most recent figure standing at $12.2 million for Q4 2025.
- In Q4 2025, Asset Writedowns and Impairment changed N/A year-over-year to $12.2 million; the TTM figure through Dec 2025 stood at $12.2 million (down 55.15% YoY), while the FY2025 annual figure was $12.2 million, down 55.15% from the prior year.
- Asset Writedowns and Impairment for Q4 2025 stood at $12.2 million, down from $27.2 million in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $306.7 million in Q2 2023, with the low at $12.2 million in Q4 2025.
- The 3-year median for Asset Writedowns and Impairment is $27.2 million (2024), against an average of $115.4 million.
- Peak annual rise in Asset Writedowns and Impairment reached 91.13% in 2024, while the deepest fall reached 91.13% in 2024.
- Emergent BioSolutions' Asset Writedowns and Impairment stood at $306.7 million in 2023, then sank by 91.13% to $27.2 million in 2024, then slumped by 55.15% to $12.2 million in 2025.
- Business Quant data shows EBS's Asset Writedowns and Impairment at $12.2 million in Q4 2025, $27.2 million in Q2 2024, and $306.7 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Emergent BioSolutions | 251.81 Mn | 110.91 Mn | 137.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 191.30 Mn |
| Jun 30, 2026 | 191.30 Mn |
| Dec 31, 2025 | 12.20 Mn |
| Dec 31, 2025 | 12.20 Mn |
| Jun 30, 2024 | 27.20 Mn |
| Jun 30, 2024 | 27.20 Mn |
| Jun 30, 2023 | 306.70 Mn |
| Jun 30, 2023 | 306.70 Mn |
| Dec 31, 2019 | 12.00 Mn |
| Dec 31, 2019 | 12.00 Mn |
| Jun 30, 2018 | 229,000.00 |
| Jun 30, 2018 | 229,000.00 |
| Mar 31, 2018 | 34,000.00 |
| Mar 31, 2018 | 34,000.00 |
| Dec 31, 2016 | 1.85 Mn |
| Dec 31, 2016 | 1.85 Mn |
| Sep 30, 2016 | 2.64 Mn |
| Sep 30, 2016 | 2.64 Mn |
| Dec 31, 2015 | 1.15 Mn |
| Dec 31, 2015 | 1.15 Mn |